Novo Nordisk CEO Lars Jrgensen previously told Yahoo Finance, "There is room for competition, there is room for choice." Eli Lilly CEO David Ricks similarly noted that it was really a matter of making the right moves to maintain the market lead
Use Melanotan-2 at the lowest effective dose for pigmentation
The retail pharmacies segment led the GLP-1 targeted peptide weight loss drugs market in 2024 due to their widespread accessibility and convenience for patients
When this system is out of balance, it can lead to symptoms like noise sensitivity, difficulty settling, increased irritability, or even panic-like episodes
Complications of intracavitary brachytherapy for gynecologic cancers and their management: a comprehensive review
Novo Nordisk's Ozempic and Wegovy combined generated USD 18.8 billion in 2023 revenue, making it the best-selling pharmaceutical product launch of the past decade